Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Respiratory Tolerance to I.V. Versus Sublingual Sedation During Bronchoscopy. (TORSIV)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men or women aged between 18 and 80, who will undergo bronchoscopy~* FEV1≥ 50% of theorical value~* Ambient air saturation at rest ≥ 94%~* No allergy to midazolam, to hydroxyzine, Lidocaine (used for local anesthesia) or one of their compound~* fasting for at least 6 hours~* No indication against bronchoscopy, nor to premedication~* Informed consent signed~Exclusion Criteria:~* Pregnant or lactating, women~* PAH patients~* patients undergoing bronchoscopy with bronchoalveolar lavage and / or trans-bronchial biopsy~* Patients with oral anticoagulants

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- I.V. sedation (Type: EXPERIMENTAL): Patients who will undergo bronchoscopy will be followed during one day. They will be randomized in the I.V. sedation
- sublingual sedation (Type: ACTIVE_COMPARATOR): Patients who will undergo bronchoscopy will be followed during one day. They will be randomized in the sublingual sedation group

Based on this trial design, predict the completion outcome and termination type (if applicable).